Altamira Therapeutics logo

Altamira Therapeutics share price today

(CYTO)

Altamira Therapeutics share price is $0.3 & ₹25.74 as on 20 Dec 2024, 2.30 'hrs' IST

$0.3

Market is closed - opens 8 PM, 07 Jan 2025

View live Altamira Therapeutics share price in Dollar and Rupees. Guide to invest in Altamira Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Altamira Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Altamira Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.3
Open
$0.4158
Market Capitalization
$1.1M
Today's Volume
$45.4K
Revenue TTM
$120.3K
EBITDA
$-5.8M
Earnings Per Share (EPS)
$1.82
PE Ratio
0.16
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-368.78%

How to invest in Altamira Therapeutics from India?

It is very easy for Indian residents to invest directly in Altamira Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Altamira Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Altamira Therapeutics or CYTO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Altamira Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Altamira Therapeutics shares which would translate to 2.860 fractional shares of Altamira Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Altamira Therapeutics, in just a few clicks!

Returns in Altamira Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Altamira Therapeutics investment value today

Current value as on today

₹12,838

Returns

₹87,162

(-87.16%)

Returns from Altamira Therapeutics Stock

₹90,385 (-90.38%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Altamira Therapeutics

100%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Altamira Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 100% more investors are searching Altamira Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Altamira Therapeutics

  • Armistice Capital, LLC

    2.68%

  • Citadel Advisors Llc

    0.39%

Analyst Recommendation on Altamira Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Altamira Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Altamira Therapeutics

What analysts predicted

Upside of 1579.47%

Current:

$0.30

Target:

$5.04

Altamira Therapeutics Technicals Summary

Sell

Neutral

Buy

Altamira Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Altamira Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

About Altamira Therapeutics

altamira therapeutics (former auris medical) is dedicated to developing therapeutics that address important unmet medical needs. the company is currently active in three areas: • the development of rna therapeutics for extrahepatic therapeutic targets (oligophore™ / semaphore™ platforms; preclinical), • nasal sprays for protection against airborne viruses and allergens (bentrio™; commercial) or the treatment of vertigo (am-125; phase 2) • the development of therapeutics for intratympanic treatment of tinnitus or hearing loss (keyzilen® and sonsuvi®, phase 3). the company was founded in 2003, under the name auris medical, and is headquartered in hamilton, bermuda with its main operations in basel, switzerland. the shares of altamira therapeutics ltd. trade on the nasdaq capital market under the symbol “cyto.”
Organization
Altamira Therapeutics
Employees
10
CEO
Dr. Thomas Meyer Ph.D.
Industry
Miscellaneous

Management People of Altamira Therapeutics

NameTitle
Dr. Thomas Meyer Ph.D.
Founder, President, Chairman, CEO & MD
Mr. Marcel Gremaud CPA
Chief Financial Officer
Dr. Covadonga Paneda
Chief Operating Officer
Dr. Samuel A. Wickline M.D.
Chief Scientific Adviser

Important FAQs about investing in Altamira Therapeutics from India :

What is Altamira Therapeutics share price today?

Altamira Therapeutics share price today stands at $0.30, Open: $0.42 ; Previous Close: $0.30 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}. The stock opens at $0.42, after a previous close of $0.30. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

Can Indians buy Altamira Therapeutics shares?

Yes, Indians can invest in the Altamira Therapeutics (CYTO) from India.

With INDmoney, you can buy Altamira Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Altamira Therapeutics at zero transaction cost.

How can I buy Altamira Therapeutics shares from India?

It is very easy to buy Altamira Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Altamira Therapeutics be purchased?

Yes, you can buy fractional shares of Altamira Therapeutics with INDmoney app.

What are the documents required to start investing in Altamira Therapeutics stocks?

To start investing in Altamira Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Altamira Therapeutics

Today’s highest price of Altamira Therapeutics (CYTO) is {{1_rba_end}}.

Today’s lowest price of Altamira Therapeutics (CYTO) is {{1_rba_st}}.

What is today's market capitalisation of Altamira Therapeutics

Today's market capitalisation of Altamira Therapeutics CYTO is 1.6M

What is the 52 Week High and Low Range of Altamira Therapeutics

  • 52 Week High

    {{rba_end}}

  • 52 Week Low

    {{rba_st}}

What are the historical returns of Altamira Therapeutics?

  • 1 Month Returns

    -38.83%

  • 3 Months Returns

    -76%

  • 1 Year Returns

    -90.38%

  • 5 Years Returns

    -99.97%

Who is the Chief Executive Officer (CEO) of Altamira Therapeutics

Dr. Thomas Meyer Ph.D. is the current Chief Executive Officer (CEO) of Altamira Therapeutics.